RxAnte develops health technology and clinical services that assess the risk of unsafe medication use and drive better prescribing and adherence, primarily through its Mosaic Pharmacy Service subsidiary. Its analytics platform supports health plans in managing value-based pharmacy care, targeting vulnerable populations with advanced drug therapy management needs. As of 2026, the company oversees pharmacy care for more than 34 million covered lives in partnership with health plans. Peer-reviewed studies conducted with UPMC Health Plan have validated RxAnte’s model, showing reduced hospitalizations and lower overall medical costs. Led by Co-Founder and CEO Josh Benner, the company plans to use new capital to scale its value-based pharmacy solutions and broaden its clinical service offerings. Although specific revenue figures were not disclosed, the firm has attracted repeat investment from strategic partner UPMC Enterprises, underscoring its commercial traction and growth potential.

Total raised

$25M

Funding rounds

3

Latest round

Equity

Latest activity

Dec 2022